Verastem (VSTM) Shares Outstanding (2011 - 2026)
Verastem's (VSTM) quarterly Shares Outstanding (Entity) came in at $26.9 million in Q2 2024, up 51.57% year-on-year from $17.7 million in Q3 2023, and up 6.2% quarter-over-quarter from $25.3 million in Q1 2024.
Verastem (VSTM) Shares Outstanding (2011 - 2026) Analysis & Trends
Verastem's Shares Outstanding (Entity) history runs 13 years deep, the most recent figure standing at $26.9 million for Q2 2024.
- On a quarterly basis, Shares Outstanding (Entity) rose 51.57% year-over-year to $26.9 million in Q2 2024; TTM through Jun 2024 was $26.9 million, a 51.57% increase from a year earlier, with the FY2023 full-year figure at $25.3 million, up 51.28% from the prior year.
- Shares Outstanding (Entity) grew to $26.9 million in Q2 2024 per VSTM's latest filing, from $25.3 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $26.9 million in Q2 2024 and bottomed at $9.0 million in Q1 2020.
- The 5-year median for Shares Outstanding (Entity) is $15.6 million (2022), against an average of $17.4 million.
- Across the five-year window, Shares Outstanding (Entity) surged 129.22% in 2020 and advanced 1.62% in 2021, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $14.2 million in 2020, then grew by 8.7% to $15.4 million in 2021, then increased by 8.23% to $16.7 million in 2022, then surged by 51.28% to $25.3 million in 2023, then rose by 6.31% to $26.9 million in 2024.
- Per Business Quant, the three latest VSTM Shares Outstanding (Entity) figures stand at $26.9 million (Q2 2024), $25.3 million (Q1 2024), and $25.3 million (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 47.82 Bn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.44 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 11.23 Bn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | 98.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.29 Mn |
| Dec 31, 2025 | 69.31 Mn |
| Sep 30, 2025 | 73.16 Mn |
| Jun 30, 2025 | 66.14 Mn |
| Mar 31, 2025 | 54.17 Mn |
| Dec 31, 2024 | 35.71 Mn |
| Sep 30, 2024 | 40.26 Mn |
| Jun 30, 2024 | 26.86 Mn |
| Mar 31, 2024 | 26.83 Mn |
| Dec 31, 2023 | 22.05 Mn |
| Sep 30, 2023 | 26.79 Mn |
| Jun 30, 2023 | 17.73 Mn |
| Mar 31, 2023 | 16.72 Mn |
| Dec 31, 2022 | 16.14 Mn |
| Sep 30, 2022 | 16.43 Mn |
| Jun 30, 2022 | 15.54 Mn |
| Mar 31, 2022 | 15.52 Mn |
| Dec 31, 2021 | 14.53 Mn |
| Sep 30, 2021 | 14.99 Mn |
| Jun 30, 2021 | 14.33 Mn |